Prime Medicine, Inc. (NASDAQ: PRME)
$3.1900
+0.2200 ( +4.93% ) 487.6K
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
Market Data
Open
$3.1900
Previous close
$2.9700
Volume
487.6K
Market cap
$410.53M
Day range
$2.9400 - $3.2350
52 week range
$2.8500 - $9.8600
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
10-q | Quarterly Reports | 62 | May 10, 2024 |
8-k | 8K-related | 15 | May 10, 2024 |
ars | Annual reports | 1 | Apr 29, 2024 |
def | Proxies and info statements | 4 | Apr 29, 2024 |
pre | Proxies and info statements | 4 | Apr 19, 2024 |
4 | Insider transactions | 1 | Mar 04, 2024 |
8-k | 8K-related | 16 | Mar 01, 2024 |
10-k | Annual reports | 115 | Mar 01, 2024 |
3 | Insider transactions | 1 | Feb 29, 2024 |
4 | Insider transactions | 1 | Feb 27, 2024 |